The WHO announced yesterday that 13 producers of single-drug artemisinin medicines for malaria have agreed to voluntarily phase them out in order to slow the progressions of drug resistance.
Disclaimer
CGD blog posts reflect the views of the authors, drawing on prior research and experience in their areas of expertise. CGD is a nonpartisan, independent organization and does not take institutional positions.
Commentary Menu